Firoza Davies
Overview
Explore the profile of Firoza Davies including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fong W, Howells L, Muller I, Mitchell E, Baker A, Thuma L, et al.
NIHR Open Res
. 2025 Feb;
4:63.
PMID: 39927124
Background: A priority setting partnership for eczema (syn atopic eczema, atopic dermatitis) has identified that bathing frequency is a key area of patient interest. However, there are nolarge, high-quality randomised...
2.
May P, Davies F, Yeowell G, Littlewood C
PLoS One
. 2024 Dec;
19(12):e0316516.
PMID: 39739611
Background: Shoulder fractures (proximal humerus fractures) are common, painful, debilitating injuries. Recovery is a long process often hindered by complications such as mal-union and frozen shoulder. The purpose of this...
3.
Simons G, Jones H, Clarke I, Davies F, Grealis S, Insch E, et al.
Res Involv Engagem
. 2024 Nov;
10(1):117.
PMID: 39506862
Background: The value of patient and public involvement (PPI) during the earliest stages of clinical trial development, and prior to the award of substantive funding, is widely recognised. However, it...
4.
Majeed A, Quint J, Bhatt S, Davies F, Islam N
BMJ
. 2024 Oct;
387:e080528.
PMID: 39374974
No abstract available.
5.
Hoppe I, Watson S, Kemp C, Turnbull F, Davies F, Gibson J, et al.
Health Expect
. 2024 Sep;
27(5):e70018.
PMID: 39229810
Introduction: Bipolar disorder is a recurrent mental health disorder with a prevalence rate of 1.4%. On average, there can be a delay of 9.5 years from the initial presentation of...
6.
El-Nayir M, Wijesurendra R, Preiss D, Mafham M, Tsiotos L, Islam S, et al.
Trials
. 2024 Aug;
25(1):554.
PMID: 39175005
Introduction: ASCEND PLUS is a randomised controlled trial assessing the effects of oral semaglutide on the primary prevention of cardiovascular events in around 20,000 individuals with type 2 diabetes in...
7.
Geraghty A, Becque T, Roberts L, Hill J, Foster N, Yardley L, et al.
Lancet Rheumatol
. 2024 Jun;
6(7):e424-e437.
PMID: 38824934
Background: Low back pain is prevalent and a leading cause of disability. We aimed to determine the clinical and cost-effectiveness of an accessible, scalable internet intervention for supporting behavioural self-management...
8.
Wilcox C, Odeh N, Clark T, Muller I, Becque T, Todd A, et al.
J Antimicrob Chemother
. 2024 May;
79(6):1441-1449.
PMID: 38708643
Introduction: FebriDx® is a CE-marked, single-use point-of-care test with markers for bacterial [C-reactive protein (CRP)] and viral [myxovirus resistance protein A (MxA)] infection, using finger-prick blood samples. Results are available...
9.
Rutter J, Wilcox C, Odeh N, Muller I, Clark T, Little P, et al.
BJGP Open
. 2024 Apr;
8(3).
PMID: 38688532
Background: FebriDx is a single-use, analyser-free, point-of-care test with markers for bacterial (C-reactive protein [CRP]) and viral (myxovirus resistance protein A [MxA]) infection, measured on a finger-prick blood sample. Aim:...
10.
Scantlebury A, Sivey P, Anteneh Z, Ayres B, Bloor K, Castelli A, et al.
BMJ Open
. 2024 Apr;
14(4):e086338.
PMID: 38643003
Introduction: The waiting list for elective surgery in England recently reached over 7.8 million people and waiting time targets have been missed since 2010. The high-volume low complexity (HVLC) surgical...